Iatrogenic Cushing’s Syndrome: The Result of Cobicistat and Glucocorticoid Interaction in an HIV Patient After Bariatric Surgery

Cobicistat, used as a pharmacokinetic booster in therapeutic combination with human immunodeficiency virus (HIV) protease inhibitors and integrase inhibitors, is a strong inhibitor of cytochrome P450 3A4 (CYP3A4). Since most glucocorticoids are metabolized by the isoenzyme of the cytochrome P450 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Benido Silva, Vânia, Cardoso, Joana, Esteves Brandão, Maria, Mesquita, Isabel, Pereira, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975894/
https://www.ncbi.nlm.nih.gov/pubmed/36874659
http://dx.doi.org/10.7759/cureus.34367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975894/
https://www.ncbi.nlm.nih.gov/pubmed/36874659
http://dx.doi.org/10.7759/cureus.34367

Ejemplares similares